
Commentary|Podcasts|July 14, 2023
Pharmacy Focus: Psychedelic Pharmacy - Digital Therapeutics in Psychedelic Medicine
David Keene, vice president of Digital Therapeutics at atai Life Sciences, discussed the growth and future of digital therapeutics.
Advertisement
This month, we sat down with David Keene, vice president of Digital Therapeutics at atai Life Sciences, to discuss the growth and future of digital therapeutics.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rocatinlimab Demonstrates Significant Efficacy and Safety in Phase 3 Trials for Moderate-to-Severe Atopic Dermatitis
2
Emerging Therapeutic Strategies Transforming Myelofibrosis Care in 2026
3
Circulating Extracellular Vesicles Contribute to Heart Failure Pathogenesis in CKD
4
Trends in Medication Management: Daily Efficiencies, Amplified Across Health Systems
5
















